Clinical trialPhase 3Terminated
Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer
Chemotherapy With or Without Preventive Anticoagulation for Metastatic Cancer of the Pancreas
- Outcome
- Stopped earlyrecruitment prematurely stopped due to a lack of eligible patients. (Enrollment)
- Phase
- Phase 3
- Status
- Terminated
- Study type
- Interventional
- Start
- October 2007
- Expected end
- December 2012
- Enrollment
- 42 participants
- Sites
- 6
- Primary outcomes
- Thromboembolic events
- Sponsor
- Other
- Results posted
- No
- Last update
- 13 March 2013
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try